menu
    • menu

    Company profile for Enzymatica

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray that protects against the common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms, and soothes...
    Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray that protects against the common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms, and soothes sore throat. The product has been launched in about 30 markets on three continents.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnzymaticaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Ideon Science Park, SE-223 70 Lund
    Telephone
    Telephone
    +46 462863100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enzymatica.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enzymatica/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/enzymatica_ab

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enzymatica's New CEO Drives International Expansion Phase
    Enzymatica's New CEO Drives International Expansion Phase

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/year-end-report-2025-new-ceo-takes-the-helm--initiates-the-next-phase-of-enzymaticas-international-expansion-302691419.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    Enzymatica AB: Reports Strong Q3/2025: Growth In Sweden
    Enzymatica AB: Reports Strong Q3/2025: Growth In Sweden

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enzymatica-ab-quarterly-report-q32025-strong-development-in-sweden-and-continued-focus-on-international-expansion-302599565.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Enzymatica AB Sees Strong Growth in Sweden
    Enzymatica AB Sees Strong Growth in Sweden

    17 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/quarterly-report-q22025-strong-development-in-sweden-and-increased-international-activity-enzymatica-ab-302507728.html

    PR NEWSWIRE
    17 Jul 2025
    Share Share
    Studies Show ColdZyme Reduces Respiratory Infections & Sick Days
    Studies Show ColdZyme Reduces Respiratory Infections & Sick Days

    28 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-independent-studies-show-that-coldzyme-addresses-the-root-cause-of-respiratory-infections-reducing-sick-days-and-symptoms-302388714.html

    PR NEWSWIRE
    28 Feb 2025
    Share Share
    Enzymatica AB 2024 Year-end Report: Strong Core Market Performance
    Enzymatica AB 2024 Year-end Report: Strong Core Market Performance

    18 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enzymatica-ab-year-end-report-2024-strong-performance-in-core-markets--preparing-for-international-growth-302378716.html

    PR NEWSWIRE
    18 Feb 2025
    Share Share
    Enzymatica AB Reports Q3 2024 Focus on Market Expansion
    Enzymatica AB Reports Q3 2024 Focus on Market Expansion

    07 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enzymatica-abs-interim-report-q32024-focus-on-developing-existing-and-new-markets-302298528.html

    PR NEWSWIRE
    07 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search